Cargill signs onto biotech joint venture for acrylic acid

Will produce biotech version of oil-based chemical

August 18, 2012 at 12:53AM

Cargill Inc. announced on Friday that it has signed an agreement with BASF and Novozymes to develop technologies to produce a biotech version of acrylic acid.

Acrylic acid, a fairly common chemical, is currently produced from propylene, which is ultimately derived from crude oil.

Minnetonka-based Cargill is an agribusiness giant with a hand in biotechnology; Germany-based BASF is one of the world's largest chemical companies; and Denmark-based Novozymes is a global leader in industrial enzymes.

BASF is also the world's largest producer of acrylic acid; it plans to initially use biotech-based acrylic acid to manufacture super-absorbent polymers. Such polymers are heavily used in baby diapers and other hygiene products.

Acrylic acid also is used in adhesives and coatings. The annual global market for acrylic acid is about $11 billion, and it has been growing at a rate of 4 percent per year.

MIKE HUGHLETT

about the writer

about the writer

Mike Hughlett

Reporter

Mike Hughlett covers energy and other topics for the Minnesota Star Tribune, where he has worked since 2010. Before that he was a reporter at newspapers in Chicago, St. Paul, New Orleans and Duluth.

See Moreicon

More from Business

See More
card image
Jerry Holt/The Minnesota Star Tribune

The Maplewood-based company announced in 2022 it would cease producing using the “forever chemical” in the span of three years, though it still expects to use third-party PFAS in some products.

card image